Ortho’s dual slide testing platform under USFDA reviewMay 8, 2019
Ortho Clinical Diagnostics has received CE Mark for Ortho’s Vitros XT MicroSlide, a new multi-test technology that allows labs to run two tests simultaneously.
Ortho’s Vitros XT MicroSlide is powered by Digital Chemistry, an optics technology that gleans significantly more information from each test than before, in less time and with less patient sample.
It simultaneously performs two tests that are commonly ordered together from a single small blood sample. This improves lab productivity and turnaround time while simplifying inventory management and optimizing storage space.
The individual, dual-test slides include paired assays for blood urea nitrogen and creatinine ratios; triglycerides and cholesterol; and glucose and calcium levels, all for use on the Vitros XT 7600 Integrated System.
Vitros XT MicroSlide is currently under review by the FDA.